Executive Summary
The October 6, 2026 MCA M&A tracker reveals a flurry of corporate restructuring activity across Indian markets, with 20 filings spanning demergers, acquisitions, and subsidiary incorporations. The healthcare sector stands out with KIMS announcing four separate acquisitions totaling up to ₹135 crore, signaling aggressive expansion in Tier-2/3 hospital markets despite target losses.
The manufacturing and infrastructure sectors show mixed signals: Endurance Technologies' European acquisition offers strategic value at a discount to net worth, while Visagar Polytex's composite scheme highlights a distressed turnaround with accumulated losses of ₹30.9 crore. A notable trend is the proliferation of SPV incorporations (ACME Solar, Zodiac Energy, Amber Enterprises) indicating sectoral diversification into renewables and electronics. Insider activity is limited, but promoter buying at iValue Infosolutions and the change in control at Baba Arts suggest selective confidence. Forward-looking catalysts include NCLT hearings for IRM Energy and Shristi Infrastructure's demerger, with completion timelines ranging from immediate to 24 months. Overall, the digest reflects a market favoring strategic consolidation and diversification, with investors needing to differentiate between value-accretive deals and high-risk turnarounds.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Filing types in this digest: M&A
Tracking the trend? Catch up on the prior India Merger Acquisition MCA Regulatory Filings digest from October 05, 2026.
Investment Signals (11)
- KIMS (BULLISH)▲
Four acquisitions totaling ₹135 crore expand presence in Andhra Pradesh and Telangana, targeting 51% stakes in Insignia Healthcare and Sarvottam Health Care with the latter showing steady revenue growth (₹74.36 Cr FY24 to ₹84.83 Cr FY26)
- Endurance Technologies ↓ (BULLISH)▲
Acquired Anna Milena and Fondalpress for €12.34M, but effective net consideration is only ~€2.24M after cash balances; Fondalpress's net worth of €20.40M implies a significant discount to book value
- India Glycols ↓ (BULLISH)▲
Demerger effective September 1, 2026, with shareholders receiving 1 IGL Spirits share per share held, creating a pure-play spirits entity; cost allocation guidance (47.62% to IGL Spirits) provides tax clarity
- TVS Supply Chain Solutions ↓ (BULLISH)▲
JV with ALA Mena in aerospace and defense sector, with ₹19.99 crore investment, positions for high-growth government and defense contracts despite current insignificant turnover
- Baba Arts ↓ (BULLISH)▲
Change in control with unnamed acquirer taking over promoter stake, board reconstitution planned for October 9, 2026, likely to bring new strategic direction
- iValue Infosolutions ↓ (BULLISH)▲
Promoter Krishna Raj Sharma acquired 35,661 shares in Q2 2026, showing insider confidence despite no mandatory disclosure requirement
- Laurus Labs ↓ (NEUTRAL)▲
Maintained 26% stake in Kurnool Renewables with ₹12.1 crore rights issue investment, supporting renewable energy integration
- Arvind Limited ↓ (NEUTRAL)▲
Acquired 46% of Arvind GCC, a new shared services entity, at face value, indicating low-cost consolidation of support functions
- Repro India ↓ (NEUTRAL)▲
Completed 100% acquisition of Repro LLC in Sharjah, expanding international footprint in media services
- Shristi Infrastructure ↓ (NEUTRAL)▲
Demerger of Krishnagar Sentrum (18.37% of turnover) into subsidiary with 2:9 share swap, unlocking value in real estate assets
- AXISCADES Technologies ↓ (NEUTRAL)▲
Incorporated XIDA Deeptech in semiconductor and AI sectors, signaling entry into high-growth deep tech markets
Risk Flags (9)
- Visagar Polytex↓ [HIGH RISK]▼
Severe financial distress with accumulated losses of ₹30.9 crore, turnover collapsed to nil in FY2024-25 from ₹71,017 lakh in FY2019-20, and fire incident halted operations indefinitely
- KIMS/Splendid Hospitals [MEDIUM RISK]▼
Target reported net loss of ₹8.92 crore on revenue of only ₹1.39 crore in FY26, with net worth of ₹38.69 crore; 22% stake acquisition for ₹40 crore implies high valuation risk
- KIMS/Ushahkal Abhinav [MEDIUM RISK]▼
Target reported net loss of ₹23.59 crore on turnover of ₹80.42 crore in FY26, indicating operational inefficiencies despite 316-bed capacity
- KIMS/Insignia Healthcare [MEDIUM RISK]▼
Target reported net loss of ₹13.28 crore in FY24-25, with acquisition completion spread over 12-24 months, exposing KIMS to prolonged turnaround risk
- Endurance Technologies↓ [MEDIUM RISK]▼
Fondalpress's declining turnover and swing to loss in latest year, despite net worth discount, may indicate operational challenges
- TVS Supply Chain Solutions↓ [LOW RISK]▼
Target entity's turnover insignificant for last 3 years, and acquisition is expected to contribute only through future expansion, with no immediate revenue impact
- Shristi Infrastructure↓ [LOW RISK]▼
Demerger subject to multiple approvals (stock exchanges, shareholders, creditors, NCLT), with potential delays or rejection
- IRM Energy↓ [LOW RISK]▼
Scheme of Amalgamation pending NCLT sanction, with no financial details disclosed, creating uncertainty
- Baba Arts↓ [LOW RISK]▼
Acquirer identity undisclosed, creating regulatory and governance uncertainty
Opportunities (10)
- KIMS/Sarvottam Health Care (OPPORTUNITY)◆
Target with 183 beds and growing revenue (₹84.83 Cr FY26, +4.2% YoY) in Kakinada, acquisition expected to complete by October 31, 2026, offering immediate scale
- Endurance Technologies↓ (OPPORTUNITY)◆
Effective net consideration of ~€2.24M for assets with combined net worth of €21.8M, providing significant asset backing and strategic European footprint
- India Glycols↓ (OPPORTUNITY)◆
Post-demerger, India Glycols retains 31.77% cost allocation, while Ennature Bio Pharma and IGL Spirits become separately listed entities, potentially unlocking value
- TVS Supply Chain Solutions↓ (OPPORTUNITY)◆
Entry into aerospace and defense via JV with ALA Mena, leveraging India's defense procurement push, with potential for high-margin contracts
- Repro India↓ (OPPORTUNITY)◆
Acquisition of Repro LLC in Sharjah Media City provides access to Middle East publishing market, with potential for cross-border synergies
- Shristi Infrastructure↓ (OPPORTUNITY)◆
Demerger of Krishnagar Sentrum into SRHL with 2:9 share swap could unlock value in mixed-use real estate, with appointed date October 1, 2026
- Laurus Labs↓ (OPPORTUNITY)◆
Continued investment in Kurnool Renewables aligns with India's renewable energy push, potentially reducing long-term energy costs
- ACME Solar↓ (OPPORTUNITY)◆
Incorporation of 18 SPVs signals aggressive renewable project pipeline, with each SPV ready for project-specific funding
- Zodiac Energy↓ (OPPORTUNITY)◆
New SPV for solar IPP and EPC projects supports growth in India's solar market, with minimal initial capital
- Amber Enterprises↓ (OPPORTUNITY)◆
Entry into mobile phone manufacturing via new subsidiary could diversify revenue streams in electronics, with potential for government PLI benefits
Sector Themes (6)
- Healthcare Consolidation◆
KIMS's four acquisitions in one day highlight aggressive consolidation in Tier-2/3 hospital markets, with targets showing revenue growth but losses, indicating a buy-and-turnaround strategy
- Renewable Energy SPV Proliferation◆
ACME Solar (18 SPVs) and Zodiac Energy (1 SPV) demonstrate a trend of creating project-specific entities to facilitate funding and risk isolation in solar projects
- Manufacturing Diversification◆
Amber Enterprises (mobile phones) and AXISCADES (deep tech) are diversifying into high-growth electronics and semiconductor sectors, reflecting a broader shift towards technology-enabled manufacturing
- Cross-Border Expansion◆
Endurance Technologies (Italy) and Repro India (UAE) are expanding internationally, seeking strategic assets and market access, with Endurance's deal at a discount to net worth
- Distressed Asset Turnarounds◆
Visagar Polytex's composite scheme and KIMS's acquisitions of loss-making hospitals indicate a theme of acquiring distressed assets for potential turnaround, with varying risk profiles
- Corporate Restructuring via Demergers◆
India Glycols and Shristi Infrastructure are using demergers to unlock value, with share swaps and tax guidance providing clarity for investors
Watch List (8)
-
Board meeting on October 9, 2026, to finalize change in control; watch for acquirer identity and strategic plans
-
NCLT hearing on Scheme of Amalgamation with Enertech Distribution; watch for approval timeline and terms
-
Demerger approvals from stock exchanges, shareholders, and NCLT; watch for timeline and any conditions
- KIMS/Sarvottam Health Care👁
Acquisition completion expected by October 31, 2026; watch for regulatory approvals and integration progress
- KIMS/Insignia Healthcare👁
Creeping acquisition over 12-24 months; watch for milestone updates and target performance
-
NCLT hearing on composite scheme; watch for approval and revival plan execution
-
Post-demerger trading of Ennature Bio Pharma and IGL Spirits; watch for listing dates and initial performance
-
JV integration and first contracts in aerospace/defense; watch for order wins
Filing Analyses
(20)
06-10-2026
Baba Arts Ltd has informed BSE that a board meeting will be held on October 9, 2026 to take note of the acquisition of the promoter's shareholding by an unnamed Acquirer pursuant to an SPA and SAST Regulations. The meeting will also appoint the Acquirer's nominees as additional directors, accept resignations of existing directors and key managerial personnel, reconstitute board committees, appoint a Managing Director and CFO, and approve the annual report for FY2026. This signals a change in control and management of the company.
- · Board meeting date: October 9, 2026 at 1:30 p.m. at registered office in Mumbai.
- · Agenda includes: appointment of internal auditor for FY2026-27, fixing date/time/mode of 27th Annual General Meeting, and other matters incidental to change in management and control.
- · The Acquirer is not named in the filing.
06-10-2026
India Glycols Limited has provided shareholders with guidance on apportioning the cost of acquisition of equity shares following the demerger of its Bio Pharma and Spirits & Biofuel undertakings into Ennature Bio Pharma Limited (Resulting Company 1) and IGL Spirits Limited (Resulting Company 2), effective September 1, 2026. The cost allocation percentages are: 31.77% for India Glycols, 20.61% for Ennature Bio Pharma, and 47.62% for IGL Spirits. This is a procedural tax guidance communication and does not contain any financial performance data.
- · The Scheme of Arrangement was sanctioned by the NCLT, Allahabad Bench, Prayagraj on July 17, 2026, and became effective from September 1, 2026.
- · Share entitlement ratio: 1 share of Ennature Bio Pharma for every 3 shares held in India Glycols; 1 share of IGL Spirits for every 1 share held in India Glycols.
- · The record date for determining eligible shareholders was September 2, 2026.
- · The guidance is based on the Income Tax Act, 2025 (corresponding to Section 2(19AA) of the erstwhile Income-tax Act, 1961).
06-10-2026
Laurus Labs Limited has invested INR 12,09,60,500 (₹12.096 Cr) to acquire 1,20,96,050 equity shares of its associate company Kurnool Renewables Private Limited (KRPL) through a rights issue, maintaining its 26% shareholding. This investment follows an earlier intimation dated March 28, 2025, and increases the company's total holding in KRPL to 2,11,68,000 equity shares of INR 10 each.
- · The investment was made by way of a rights issue.
- · The company's shareholding percentage in KRPL remains unchanged at 26%.
- · The investment is a follow-up to an intimation dated March 28, 2025.
06-10-2026
IRM Energy Limited has filed a petition seeking sanction for a Scheme of Amalgamation with Enertech Distribution Management Private Limited. The National Company Law Tribunal (NCLT), Ahmedabad Bench, has ordered a hearing on the petition, and the company has published newspaper advertisements as required under Regulation 30 of SEBI LODR. No financial details of the transaction have been disclosed in this filing.
- · The NCLT Ahmedabad Bench order was dated September 24, 2026.
- · Newspaper advertisements were published in The Indian Express (All India English Edition) and The Sandesh (Ahmedabad Edition) on October 06, 2026.
- · The hearing of the petition is for sanction to the Scheme of Amalgamation.
06-10-2026
Arvind Limited has completed the acquisition of 4,600 equity shares (46% stake) in Arvind Global Capability Center Private Limited for cash consideration at face value. The target is a newly incorporated company (April 1, 2026) with nil turnover, focused on providing centralized business support and shared services to group entities. The transaction is a related party transaction executed on an arm's length basis.
- · Arvind GCC was incorporated on April 1, 2026, and has nil turnover and nil size.
- · The acquisition is a related party transaction but done on an arm's length basis.
- · Consideration is cash at face value per share.
- · No governmental or regulatory approvals were required for the acquisition.
06-10-2026
Repro India Limited, through its wholly owned subsidiary Repro Books Limited, has completed the acquisition of 100% equity shares of Repro LLC, making it a step-down wholly owned subsidiary. The acquisition was finalized on October 6, 2026, following share transfer and registration formalities with SHAMS (Sharjah Media City), UAE. No financial details or consideration amounts were disclosed in this filing.
- · The acquisition was initially intimated on August 18, 2026.
- · Repro LLC is based in Sharjah, UAE, under the Sharjah Media City (SHAMS) jurisdiction.
- · Post-acquisition, Repro LLC is a wholly owned subsidiary of Repro Books Limited and a step-down wholly owned subsidiary of Repro India Limited.
06-10-2026
The Board of Shristi Infrastructure Development Corporation Limited approved a Scheme of Arrangement to demerge the Krishnagar Sentrum undertaking into its wholly owned subsidiary, Shristi Realty Holdings Limited, with an Appointed Date of October 1, 2026. The undertaking recorded turnover of INR 1,281.72 Lakh in FY 2025-26, representing 18.37% of SIDCL’s standalone turnover; however, the demerger remains subject to stock-exchange observations, shareholder and creditor approvals, NCLT sanction and other statutory approvals. No cash consideration is payable, with eligible SIDCL shareholders instead receiving 2 fully paid-up equity shares of SRHL for every 9 fully paid-up SIDCL shares.
- · The Scheme transfers Krishnagar Sentrum, including attributable assets, liabilities, contracts, employees, licenses, permits, approvals and properties, to SRHL as a going concern on an as-is-where-is basis.
- · Krishnagar Sentrum is a mixed-use project in Krishnanagar, Nadia District, West Bengal, comprising residential, retail, entertainment, hospitality and lifestyle components.
- · The Board meeting was held on October 06, 2026, commenced at 3:00 P.M. and concluded at 4:50 P.M.
- · The share entitlement ratio was supported by a report dated October 06, 2026 from Omnifin Valuation Services (OPC) P Ltd and a fairness opinion dated October 06, 2026 from Corpwis Advisors Private Limited.
- · Listing of SRHL is proposed on BSE Limited and The Calcutta Stock Exchange Limited, subject to requisite approvals and relaxation under Rule 19(7) of the Securities Contracts (Regulation) Rules, 1957.
- · The Scheme may result in minor changes to the stated SRHL shareholding because fractional shares may be consolidated and issued to a trustee.
06-10-2026
iValue Infosolutions Limited voluntarily disclosed that its promoter, Mr. Krishna Raj Sharma, acquired 35,661 equity shares via open market purchases during Q2 2026. The acquisition represents less than 2% of total shareholding and does not trigger mandatory SEBI (SAST) disclosure requirements. The company made the intimation voluntarily to keep stakeholders informed.
- · The acquisition was made via open market purchases during the second quarter of 2026.
- · The acquisition is less than 2% of total shareholding or voting rights, thus not triggering mandatory SEBI (SAST) disclosure.
- · The company voluntarily disclosed the information to keep stakeholders informed.
06-10-2026
TVS Supply Chain Solutions Limited (TVS SCS) has completed the allotment of 1,99,90,000 equity shares in its subsidiary TVS SCS ALA India Private Limited (formerly TVS Packaging Solutions Private Limited) to itself and ALA Mena, in a 51:49 ratio, pursuant to a Joint Venture Agreement. The transaction, approved by the Target Entity's Board on October 06, 2026, involves a cash consideration of INR 19,99,00,000 (INR Nineteen Crores and Ninety-Nine Lakhs) and aims to expand into India's aerospace and defense sectors. However, the Target Entity's turnover remains insignificant, and the acquisition is expected to contribute to revenue and profit growth only through future business expansion.
- · The Target Entity was a wholly owned subsidiary of TVS SCS prior to the transaction.
- · The Target Entity was incorporated on April 28, 2017, in India.
- · The Target Entity's turnover during the last 3 years was insignificant.
- · The transaction is not a related party transaction; promoters have no interest.
- · No governmental or regulatory approvals are required for the acquisition.
- · The Target Entity is focused on exploring business expansion opportunities in the logistics industry.
06-10-2026
Endurance Technologies Limited, via its wholly owned Italian subsidiary Endurance Overseas SpA, has acquired 100% of Anna Milena SpA and Fondalpress SpA for €12.34 million in cash. The acquisition strengthens Endurance's aluminium die-casting capabilities in Europe, adding strategically located assets and production capacity. Fondalpress has experienced declining turnover and swung to a loss in its most recent unaudited year, though the effective net consideration is only ~€2.24 million after accounting for the targets' cash balances.
- · Fondalpress's net worth as of Dec 2024 was €20.40 million, against an acquisition cost of €12.34 million.
- · Anna Milena's net worth as of Dec 2024 was €1.40 million; its turnover has been steady at €0.40 million for the last three years.
- · No governmental or regulatory approvals were required, and the transaction closed simultaneously with signing.
- · The acquisition is not a related party transaction and the promoter/promoter group has no interest in the target companies.
06-10-2026
ACME Solar Holdings Limited has incorporated 18 wholly owned subsidiaries on October 06, 2026, each with a paid-up capital of ₹1,00,000 (10,000 equity shares of ₹10 each). The subsidiaries are set up to undertake businesses related to power generation and renewable energy projects, with 100% cash subscription by the listed entity.
- · The subsidiaries were incorporated in Gurugram, Haryana, India.
- · No governmental or regulatory approvals were required for the incorporation.
- · The consideration was 100% cash subscription to the initial paid-up share capital.
06-10-2026
Krishna Institute of Medical Sciences Limited (KIMS) has approved the acquisition of a 6% stake in Ushahkal Abhinav Specialty Hospital LLP (Sangli) for an aggregate consideration of ₹15 Crore via primary infusion. The target entity, a quaternary care facility with 316 beds (expandable to 500+), reported a turnover of ₹80.42 Crore but a net loss of ₹23.59 Crore for FY26, indicating the investment is strategic rather than immediately profitable.
- · Target entity was incorporated on 25-11-2016.
- · Target entity reported a net loss (PAT) of ₹23.59 Crore for FY26.
- · The acquisition is not a related party transaction.
- · Completion of acquisition is expected on or before 31-10-2026.
- · Consideration is cash, based on a valuation report by BDO Valuation Advisory LLP dated 05 October 2026.
06-10-2026
Krishna Institute of Medical Sciences Limited (KIMS) has approved the acquisition of up to 51% equity stake in Insignia Healthcare Private Limited (KIMS-SIKHARA), an O&M entity operating a 150-bed hospital in Guntur, Andhra Pradesh. The acquisition will be made via cash at ₹30.35 per share based on a valuation report by BDO Valuation Advisory LLP, with completion expected within 12 to 24 months. The target company reported a turnover of ₹104.5 Cr in FY25 but a net loss of ₹13.28 Cr in FY24-25, indicating a turnaround challenge.
- · The acquisition is not a related party transaction.
- · The target company was incorporated on July 2, 2018.
- · The acquisition will be by way of creeping acquisition over an indicative period of 12 to 24 months.
- · Subsequent acquisitions after the initial purchase will be at cost based on an independent valuer's report.
- · The hospital has the potential to increase capacity from 150 to 200 beds.
06-10-2026
Krishna Institute of Medical Sciences Limited (KIMS) has approved the acquisition of up to 51% equity stake in Sarvottam Health Care Private Limited (Kakinada), an O&M entity, for an aggregate consideration of up to ₹80.00 Crore. The target, operating as Trust Multi Speciality Hospital with 183 beds, reported turnover of ₹84.83 Cr in FY26, ₹81.38 Cr in FY25, and ₹74.36 Cr in FY24, showing steady growth. The acquisition is expected to complete on or before 31.10.2026, with cash consideration based on a BDO valuation report.
- · Target entity incorporated on 19-04-2011
- · Target operates in Kakinada, Andhra Pradesh, India
- · Target has a total built-up area of approximately 9847.23 square meters on company-owned land of 3001.36 square yards
- · Target's net worth is ₹50.30 Crore as per FY26 data
- · Target's PAT is ₹70.55 Crore as per FY26 data
- · Acquisition is not a related party transaction
- · Acquisition is a strategic investment, with KIMS being the O&M partner of the target
- · No governmental or regulatory approvals required for the acquisition
- · Consideration is cash-based, based on BDO valuation report dated 05 October 2026
- · Target turnover growth slowed to 4.24% in FY26 from 9.44% in FY25
06-10-2026
Krishna Institute of Medical Sciences Limited (KIMS) has approved the acquisition of up to 22% equity stake in Splendid Hospitals Private Limited (Kompally) for an aggregate consideration of up to ₹40.00 Crore via primary infusion. The target, incorporated in September 2022, reported a turnover of ₹1.39 Crore and a net loss of ₹8.92 Crore for FY 2025-26, with a net worth of ₹38.69 Crore. While the investment is strategic for KIMS as the O&M partner, the target's financials show significant losses and minimal revenue, indicating a high-risk, long-term growth play.
- · The acquisition is expected to be completed on or before 31.03.2027.
- · The consideration is cash-based, with valuation determined by BDO Valuation Advisory LLP report dated 05th October 2026.
- · Splendid Hospitals was incorporated on 20-09-2022 and is located in Kompally, Telangana, India.
- · The target has the potential to expand to over 225+ beds and is equipped with latest medical infrastructure and multiple operation theatres.
- · The acquisition does not fall within related party transactions.
06-10-2026
Amber Enterprises India Limited has incorporated a wholly owned subsidiary, Amber Digital Technologies Private Limited, to commence the business of manufacturing mobile phones. The subsidiary was incorporated on September 18, 2026, with a total equity infusion of ₹1,00,000 (₹1 Lakh) at a 100% shareholding. This move marks Amber's strategic diversification into the mobile phone manufacturing segment, although the investment is relatively small at the initial stage.
- · The subsidiary was incorporated on 18th September 2026 in India.
- · The industry classification is Electronics and Telecommunication.
- · No governmental or regulatory approvals were required for the incorporation.
- · The consideration is in cash; no share swap involved.
06-10-2026
Zodiac Energy Limited incorporated a wholly owned subsidiary, ZODIAC ENERGY IPP-4 PRIVATE LIMITED, on October 06, 2026, with a nominal share capital of ₹10,00,000 and initial paid-up capital of ₹1,00,000. The subsidiary is a Special Purpose Vehicle (SPV) for solar power generation and EPC projects, aligning with the company's business expansion strategy. No financial performance data (e.g., turnover) is available as the entity is newly incorporated.
- · The subsidiary was incorporated under CIN U35100GJ2026PTC184717.
- · The subsidiary is classified as a Special Purpose Vehicle (SPV) for solar power generation and EPC activities.
- · No governmental or regulatory approvals were required for the incorporation.
- · The consideration was cash, with Zodiac Energy subscribing to 100% of the initial paid-up share capital of ₹1,00,000.
- · The subsidiary has zero turnover as of incorporation date.
06-10-2026
LEAP India Ltd has invested approximately INR 9.64 crore (USD 1,000,000) to subscribe to 999,999,999 equity shares of its wholly owned UAE subsidiary, LEAP MENA Holdings Limited. The newly incorporated subsidiary will be used to infuse equity or debt into its own subsidiary, LEAP Pallet Pooling Trading LLC, for business investment. The transaction is an arm's-length related-party investment under the automatic FEMA route.
- · LEAP MENA Holdings Limited was incorporated on July 1, 2026, under Abu Dhabi Global Market Companies Regulations, 2020.
- · The subsidiary is authorized to carry on the business of a holding company.
- · The investment is made under the automatic route in accordance with FEMA.
- · The exchange rate used for the remittance was $1 = INR 96.44.
- · The equity shares have a face value of $0.001 each.
- · No governmental or regulatory approval was required for the investment.
06-10-2026
AXISCADES Technologies Limited has incorporated a step-down subsidiary, XIDA DEEPTECH PRIVATE LIMITED, in India on October 05, 2026, through its holding company XIDA PRIVATE LIMITED. The new entity will operate in electronics, semiconductor, artificial intelligence and deep tech sectors. AXISCADES holds no direct shareholding and no shares were allotted, but exercises indirect control as the ultimate holding company.
06-10-2026
Visagar Polytex Limited filed a Composite Scheme of Arrangement under Sections 230-232, 66, 62 and 42 of the Companies Act, 2013. The scheme proposes a reduction of share capital to write off accumulated losses of Rs. 30,89,52,786/- as at March 31, 2026, followed by a preferential issue of equity shares and warrants to infuse fresh capital. However, the company has experienced severe and sustained losses for multiple years, with turnover declining from Rs. 71,016.96 lakh in FY2019-20 to Nil in FY2024-25, and a fire incident in September 2024 forced indefinite suspension of manufacturing operations.
- · The scheme involves reduction of share capital under Section 66, followed by preferential issue of equity shares and warrants.
- · Accumulated losses of Rs. 30,89,52,786/- as at March 31, 2026.
- · A fire incident on September 4, 2024 forced indefinite suspension of manufacturing operations.
- · Turnover declined to Nil in FY2024-25 from Rs. 2,821.06 lakh in FY2023-24 (100% decline).
- · The company has not turned a profit for several years; accumulated losses have eroded net worth.
- · The reduction of share capital does not involve any payment to shareholders.
Get daily alerts with 11 investment signals, 9 risk alerts, 10 opportunities and full AI analysis of all 20 filings
₹500/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: India Merger Acquisition MCA Regulatory Filings
October 04, 2026
India Merger Acquisition MCA Regulatory Filings — October 04, 2026
October 02, 2026
India Merger Acquisition MCA Regulatory Filings — October 02, 2026
September 30, 2026
India Merger Acquisition MCA Regulatory Filings — September 30, 2026
September 28, 2026
India Merger Acquisition MCA Regulatory Filings — September 28, 2026
🇮🇳 More from India
View all →October 07, 2026
India Pre-Market Regulatory Roundup — October 07, 2026
India Pre-Market Regulatory Roundup
October 07, 2026
India Upcoming Corporate Actions BSE NSE — October 07, 2026
India Upcoming Corporate Actions BSE NSE
October 06, 2026
India Pre-Market Regulatory Roundup — October 06, 2026
India Pre-Market Regulatory Roundup
October 06, 2026
India Quarterly Results BSE NSE Announcements — October 06, 2026
India Quarterly Results BSE NSE Announcements